EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Novel endothelial progenitor cells populations as biomarkers of damage and remission in systemic lupus erythematosus

Carlos Rafael-Vidal, Sara Martínez-Ramos, Beatriz Malvar-Fernández, Irene Altabás-González, Coral Mouriño, Pablo Pazos-López, Arturo Fraga-Bau, José María Pego Reigosa, Samuel García

Arthritis Research & Therapy · 2024

DOI: 10.1186/s13075-024-03397-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis Research & Therapy, 2024. Verfasst von Carlos Rafael-Vidal und 8 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology and Immune-Mediated Diseases Group (IRIDIS), Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Vigo, Spain. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Endothelial Progenitor Cells, Biomarkers, Flow Cytometry. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Endothelial progenitor cells (EPCs) are essential for maintenance of vascular homeostasis and stability, key processes in the pathogenesis of systemic lupus erythematosus (SLE). However, the role and phenotypic characterization of EPCs populations in SLE have not been completely elucidated. OBJECTIVE: To identify EPCs specific subpopulations in patients with SLE using a novel flow cytometry tool. METHODS: Peripheral blood mononuclear cells (PBMCs) were isolated from patients with SLE and healthy controls (HC). mRNA and surface protein expression were determined by quantitative PCR (qPCR) and flow cytometry. Clusters identification and characterization were performed using tSNE-CUDA dimensionality reduction algorithms. RESULTS: tSNE-CUDA analysis identified eight different clusters in PBMCs from HC and patients with SLE. Three of these clusters had EPC-like phenotype and the expression was elevated in patients with SLE. Moreover, four SLE-associated subclusters were found mainly expressed in patients with SLE, being only present in patients in remission with SLE and significantly associated with the 2021 Definition of Remission in SLE. Importantly, we also identified specific clusters in SLE patients with organ damage, according to the Systemic Lupus International Collaborating Clinics (SLICC)/American College of Rheumatology damage index (SDI). These clusters showed an EPC-like phenotype, but the expression of angiogenic markers was lower compared to HC or patients without organ damage, suggesting an impaired angiogenic function. CONCLUSION: Our novel approach identified clusters of EPCs in patients with SLE that are associated with remission and damage. Therefore, these clusters might be useful biomarkers to predict disease progression and severity in SLE pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicEndothelial Progenitor CellsBiomarkersFlow CytometryHumansFemaleAdultMaleMiddle AgedRemission InductionLeukocytes, Mononuclear

Stichwörter der Autor:innen

DamageEPCs clustersEndothelial progenitor cellsRemissionSystemic lupus erythematosus

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Rheumatology and Immune-Mediated Diseases Group (IRIDIS), Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Vigo, Spain.
  • Rheumatology Department, University Hospital Complex of Vigo, Vigo, Spain.
  • Department of Cardiology, University Hospital Complex of Vigo, Vigo, Spain.
  • Department of Clinical Neurology, University Hospital Complex of Vigo, Vigo, Spain.
  • Rheumatology and Immune-Mediated Diseases Group (IRIDIS), Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Vigo, Spain. jose.maria.pego.reigosa@sergas.es.
  • Rheumatology Department, University Hospital Complex of Vigo, Vigo, Spain. jose.maria.pego.reigosa@sergas.es.

Zitieren

APA

Rafael-Vidal, C., Martínez-Ramos, S., Malvar-Fernández, B., Altabás-González, I., Mouriño, C., Pazos-López, P., Fraga-Bau, A., Pego Reigosa, J. M., & García, S. (2024). Novel endothelial progenitor cells populations as biomarkers of damage and remission in systemic lupus erythematosus. Arthritis Research & Therapy. https://doi.org/10.1186/s13075-024-03397-4

Vancouver

Rafael-Vidal C, Martínez-Ramos S, Malvar-Fernández B, Altabás-González I, Mouriño C, Pazos-López P, et al. Novel endothelial progenitor cells populations as biomarkers of damage and remission in systemic lupus erythematosus. Arthritis Research & Therapy. 2024. doi:10.1186/s13075-024-03397-4

BibTeX
@article{RafaelVidal2024,
  author = {Rafael-Vidal, Carlos and Martínez-Ramos, Sara and Malvar-Fernández, Beatriz and Altabás-González, Irene and Mouriño, Coral and Pazos-López, Pablo and Fraga-Bau, Arturo and Pego Reigosa, José María and García, Samuel},
  title = {Novel endothelial progenitor cells populations as biomarkers of damage and remission in systemic lupus erythematosus},
  journal = {Arthritis Research & Therapy},
  year = {2024},
  doi = {10.1186/s13075-024-03397-4}
}
Kostenlos starten →